Urokinase (u-PA) is synthesized and secreted as a single-chain polypeptide (single-chain u-PA, scu-PA), which has such little enzymatic activity in solution that it has been considered essentially enzymatically inert. We found that plasminogen activator inhibitor type 1 (PAI-1), the major PAI in plasma, demonstrated concentration-dependent inhibition of this solution-phase scu-PA enzymatic activity. I-scu-PA formed complexes with PAI-1 in a concentration- and time-dependent manner, as detected by SDS-polyacrylamide gel electrophoresis under reducing conditions. Among a given population of scu-PA molecules, all measurable enzymatic activity was inhibited by a 10-fold molar excess of PAI-1. However, at this stoichiometry, only a minority of I-scu-PA molecules formed SDS-stable complexes with PAI-1 (i.e. complexes that formed a covalent bond upon denaturation), even though the uncomplexed PAI-1 molecules remained competent to inhibit u-PA enzymatic activity. Neither the extent nor the time course of complex formation was altered by using PAI-1 that had been pre-incubated with native human vitronectin, compared with native PAI-1 alone. I-scu-PAPAI-1 complexes that would form a covalent bond if denatured were reversible and existed in equilibrium with either non-complexed or loosely complexed reactants. These data suggest that scu-PA has more enzyme-like properties than previously appreciated and raises the possibility that it resembles single-chain tissue type-plasminogen activator in lacking a complete zymogen conformation.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				B.-S. Ding, N. Hong, J.-C. Murciano, K. Ganguly, C. Gottstein, M. Christofidou-Solomidou, S. M. Albelda, A. B. Fisher, D. B. Cines, and V. R. Muzykantov Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature Blood, February 15, 2008; 111(4): 1999 - 2006. [Abstract] [Full Text] [PDF]

				M. Wygrecka, R. E. Morty, P. Markart, S. M. Kanse, P. A. Andreasen, T. Wind, A. Guenther, and K. T. Preissner Plasminogen Activator Inhibitor-1 Is an Inhibitor of Factor VII-activating Protease in Patients with Acute Respiratory Distress Syndrome J. Biol. Chem., July 27, 2007; 282(30): 21671 - 21682. [Abstract] [Full Text] [PDF]

				S. Idell, A. Mazar, D. Cines, A. Kuo, G. Parry, S. Gawlak, J. Juarez, K. Koenig, A. Azghani, W. Hadden, et al. Single-Chain Urokinase Alone or Complexed to Its Receptor in Tetracycline-induced Pleuritis in Rabbits Am. J. Respir. Crit. Care Med., October 1, 2002; 166(7): 920 - 926. [Abstract] [Full Text]

				A. HAJ-YEHIA, T. NASSAR, B. S. SACHAIS, A. KUO, K. BDEIR, A. B. AL-MEHDI, A. MAZAR, D. B. CINES, and A. A.-R. HIGAZI Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo FASEB J, July 1, 2000; 14(10): 1411 - 1422. [Abstract] [Full Text]

				E A M Braat, A F H Jie, H K Ronday, B Beekman, and D C Rijken Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin Ann Rheum Dis, April 1, 2000; 59(4): 315 - 318. [Abstract] [Full Text]

				B. S. Schwartz and F. Espana Two Distinct Urokinase-Serpin Interactions Regulate the Initiation of Cell Surface-associated Plasminogen Activation J. Biol. Chem., May 21, 1999; 274(21): 15278 - 15283. [Abstract] [Full Text] [PDF]

				H. Lee, I. Struman, C. Clapp, J. Martial, and R. I. Weiner Inhibition of Urokinase Activity by the Antiangiogenic Factor 16K Prolactin: Activation of Plasminogen Activator Inhibitor 1 Expression Endocrinology, September 1, 1998; 139(9): 3696 - 3703. [Abstract] [Full Text] [PDF]

				D. S. Alexander, J. D. Sipley, and J. P. Quigley Autoactivation of Avian Urokinase-type Plasminogen Activator (uPA). A NOVEL MODE OF INITIATION OF THE uPA/PLASMIN CASCADE J. Biol. Chem., March 27, 1998; 273(13): 7457 - 7461. [Abstract] [Full Text] [PDF]

				C. Lenich, J.-N. Liu, and V. Gurewich Thrombin Stimulation of Platelets Induces Plasminogen Activation Mediated by Endogenous Urokinase-Type Plasminogen Activator Blood, November 1, 1997; 90(9): 3579 - 3586. [Abstract] [Full Text] [PDF]

				L. Zhang, D. K. Strickland, D. B. Cines, and A. A.-R. Higazi Regulation of Single Chain Urokinase Binding, Internalization, and Degradation by a Plasminogen Activator Inhibitor 1-Derived Peptide J. Biol. Chem., October 24, 1997; 272(43): 27053 - 27057. [Abstract] [Full Text] [PDF]

				V. Ellis and V. Ellis Functional Analysis of the Cellular Receptor for Urokinase in Plasminogen Activation. RECEPTOR BINDING HAS NO INFLUENCE ON THE ZYMOGENIC NATURE OF PRO-UROKINASE J. Biol. Chem., June 21, 1996; 271(25): 14779 - 14784. [Abstract] [Full Text] [PDF]

				R. R. Schleef and T. L. Chuang Protease Inhibitor 10 Inhibits Tumor Necrosis Factor alpha -induced Cell Death. EVIDENCE FOR THE FORMATION OF INTRACELLULAR HIGH Mr PROTEASE INHIBITOR 10-CONTAINING COMPLEXES J. Biol. Chem., August 18, 2000; 275(34): 26385 - 26389. [Abstract] [Full Text] [PDF]